Elco Management Co., LLC Biocryst Pharmaceuticals Inc Transaction History

Elco Management Co., LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $21,595 - $35,504	-5,229 Reduced 14.52%	30,792 $190,000
Q1 2024 May 14, 2024	BUY	$4.89 - $7.65 $26,249 - $41,065	5,368 Added 17.51%	36,021 $182,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $85,212 - $115,841	17,111 Added 126.36%	30,653 $183,000
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $94,252 - $119,305	13,542 New	13,542 $95,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Elco Management Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Elco Management Co., LLC with notifications on news.